Activation of Autophagy and Suppression of Apoptosis by Dapagliflozin Attenuates Inflammatory Bowel Disease
Clinical trial NCT05986136 · RECRUITING
Trial details
- NCT number
- NCT05986136
- Sponsor
- Mostafa Bahaa
- Status
- RECRUITING
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-08-20
- Primary completion
- 2027-08-20
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.